cabotegravir (Vocabria) Report issue

Small molecule Approved FDA Fast Track FDA Priority Review FDA
AACT ChEMBL DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now
Cabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva.   Wikipedia

Chemistry

  • SMILES: C[C@H]1CO[C@@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)O
  • InChIKey: WCWSTNLSLKSJPK-LKFCYVNXSA-N
  • Mol. Mass: 405.36
  • ALogP: 0.96
  • ChEMBL Molecules:
    cabotegravir  
    cabotegravir sodium  
More Chemistry

Pharmacology

Combination drugs

( cabotegravir (Vocabria), rilpivirine (edurant) - other name: cabotegravir and rilpivirine -extended release injectable suspension )

Alternative names

cabotegravir | cabotegravir sodium | gsk1265744 | gsk1265744a | gsk1265744b | gsk744 | n-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide | s-265744b

Organizations (57)

Research & Development (57)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (8)

Approved Indications (1)


 

HIV Infections (approved 2021)

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Breast Feeding (Phase 4)

Healthy Volunteers (Phase 1)

HIV (Phase 4)

HIV-Associated Lipodystrophy Syndrome (Phase 1)

HIV Infections (Phase 4)

Pre-Exposure Prophylaxis (Phase 4)

Sexually Transmitted Diseases, Viral (Phase 1)

Tuberculosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 66
  • # of Trial Organizations: 57

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue